Mera Pharmaceuticals, Inc.
MRPI
$0.00
$0.000.00%
| 10/31/2011 | 07/31/2011 | 04/30/2011 | 01/31/2011 | 10/31/2010 | |
|---|---|---|---|---|---|
| Revenue | 63.90K | 86.80K | 87.30K | 64.60K | 64.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 63.90K | 86.80K | 87.30K | 64.60K | 64.10K |
| Cost of Revenue | 2.20K | 300.00 | 10.20K | 3.50K | 35.70K |
| Gross Profit | 61.70K | 86.50K | 77.10K | 61.10K | 28.50K |
| SG&A Expenses | 117.90K | 63.90K | 64.40K | 59.90K | 41.30K |
| Depreciation & Amortization | 2.10K | 2.10K | 1.30K | 2.80K | 5.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 167.50K | 106.90K | 125.20K | 104.10K | 144.30K |
| Operating Income | -103.60K | -20.10K | -37.90K | -39.50K | -80.10K |
| Income Before Tax | -105.60K | -19.30K | -38.90K | -38.10K | -398.60K |
| Income Tax Expenses | -3.40K | -3.50K | -3.90K | -3.40K | -4.00K |
| Earnings from Continuing Operations | -102.20K | -15.80K | -35.10K | -34.70K | -394.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -102.20K | -15.80K | -35.10K | -34.70K | -394.60K |
| EBIT | -103.60K | -20.10K | -37.90K | -39.50K | -80.10K |
| EBITDA | -101.40K | -17.90K | -36.70K | -36.70K | -74.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 547.77M | 547.77M | 547.77M | 547.77M | 547.77M |
| Average Diluted Shares Outstanding | 547.77M | 547.77M | 547.77M | 547.77M | 547.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
